XML 35 R16.htm IDEA: XBRL DOCUMENT v3.20.1
Stockholder's Equity
6 Months Ended
Mar. 31, 2020
Equity [Abstract]  
Stockholder's Equity

Note 9. Stockholder’s Equity

Per the Amended and Restated Certificate of Incorporation, which was adopted on October 1, 2019, 600,000,000 shares of capital stock have been authorized, consisting of 40,000,000 shares of Preferred Stock, par value $0.01 per share, or Preferred Stock, and 560,000,000 shares of Common Stock, par value $0.01 per share, or Common Stock.

On October 2, 2019, we registered the issuance of 6,350,000 shares of Common Stock, consisting of 5,300,000 shares of Common Stock reserved for issuance upon the exercise of options granted, or in respect of awards granted, under the Cerence 2019 Equity Incentive Plan, (“Equity Incentive Plan”), and 1,050,000 shares of Common Stock that are reserved for issuance under the Cerence 2019 Employee Stock Purchase Plan.

The Equity Incentive Plan provides for the grant of incentive stock options, stock awards, stock units, stock appreciation rights, and certain other stock-based awards. Awards issued under the Plan may not have a term greater than ten years from the date of grant.

In connection with the Spin-Off from Nuance, all outstanding Nuance restricted stock units and performance stock units held by Cerence employees were cancelled, and Cerence regranted such employees economically equivalent restricted stock units of Cerence. 1,208,931 restricted stock units were issued by Cerence in connection with the Spin-Off.

 

Restricted Units

 

Information with respect to our non-vested restricted stock units for the six months ended March 31, 2020 was as follows:

 

 

Non-Vested Restricted Stock Units

 

 

Time-Based

Shares

 

Performance-

Based Shares

 

Total Shares

 

Weighted-

Average

Grant-Date

Fair Value

 

Weighted-

Average

Remaining

Contractual

Term (years)

 

Aggregate

Intrinsic

Value

(in thousands)

 

Non-vested at October 1, 2019

 

 

 

 

 

 

$

 

 

 

 

 

 

 

Granted

 

2,714,653

 

 

770,204

 

 

3,484,857

 

$

16.38

 

 

 

 

 

 

 

Vested

 

(111,494

)

 

 

 

(111,494

)

$

16.94

 

 

 

 

 

 

 

Forfeited

 

(12,901

)

 

 

 

(12,901

)

$

17.74

 

 

 

 

 

 

 

Non-vested at March 31, 2020

 

2,590,258

 

 

770,204

 

 

3,360,462

 

$

16.35

 

 

1.26

 

$

51,740

 

Expected to vest

 

 

 

 

 

 

 

3,360,462

 

$

16.35

 

 

1.26

 

$

51,740

 

 

Stock-based Compensation

 

Stock-based compensation was included in the following captions in our consolidated statements of operations for the three and six months ended March 31, 2020 and combined statement of operations for the three and six months ended March 31, 2019 (in thousands):

 

 

 

Three Months Ended March 31,

 

 

Six Months Ended March 31,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Cost of licensing

 

$

 

 

$

3

 

 

$

 

 

$

8

 

Cost of connected services

 

 

188

 

 

 

489

 

 

 

540

 

 

 

617

 

Cost of professional services

 

 

433

 

 

 

261

 

 

 

1,304

 

 

 

508

 

Research and development

 

 

1,948

 

 

 

3,290

 

 

 

4,923

 

 

 

6,744

 

Sales and marketing

 

 

1,776

 

 

 

1,566

 

 

 

3,366

 

 

 

3,034

 

General and administrative

 

 

2,215

 

 

 

1,184

 

 

 

5,396

 

 

 

2,456

 

 

 

$

6,560

 

 

$

6,793

 

 

$

15,529

 

 

$

13,367